Your browser is no longer supported. Please, upgrade your browser.
Settings
AGEN Agenus Inc. daily Stock Chart
AGEN [NASD]
Agenus Inc.
Index- P/E- EPS (ttm)-0.98 Insider Own0.80% Shs Outstand132.73M Perf Week3.23%
Market Cap509.68M Forward P/E- EPS next Y-1.38 Insider Trans0.00% Shs Float105.50M Perf Month-4.00%
Income-125.60M PEG- EPS next Q-0.38 Inst Own36.10% Short Float11.12% Perf Quarter54.84%
Sales122.00M P/S4.18 EPS this Y-17.50% Inst Trans0.23% Short Ratio8.84 Perf Half Y60.00%
Book/sh-1.45 P/B- EPS next Y-45.30% ROA-65.80% Target Price5.50 Perf Year8.47%
Cash/sh0.70 P/C5.46 EPS next 5Y- ROE77.80% 52W Range2.13 - 4.57 Perf YTD-5.65%
Dividend- P/FCF- EPS past 5Y-5.30% ROI84.50% 52W High-15.97% Beta2.24
Dividend %- Quick Ratio0.80 Sales past 5Y64.60% Gross Margin- 52W Low79.86% ATR0.19
Employees294 Current Ratio0.80 Sales Q/Q55.50% Oper. Margin-74.00% RSI (14)48.92 Volatility4.31% 4.98%
OptionableYes Debt/Eq- EPS Q/Q-14.60% Profit Margin- Rel Volume1.06 Prev Close4.01
ShortableYes LT Debt/Eq- EarningsFeb 03 BMO Payout- Avg Volume1.33M Price3.84
Recom1.30 SMA20-0.78% SMA50-2.09% SMA20026.60% Volume1,410,666 Change-4.12%
Nov-19-19Resumed B. Riley FBR Buy $6
Apr-22-19Initiated B. Riley FBR Buy
Oct-28-16Downgrade H.C. Wainwright Buy → Neutral $10 → $5
Oct-27-16Reiterated Maxim Group Buy
Mar-11-16Upgrade Maxim Group Hold → Buy $7
Dec-16-15Initiated Jefferies Buy
Oct-27-15Downgrade Maxim Group Buy → Hold
Jul-27-15Reiterated MLV & Co Buy $9 → $11
Jun-11-15Initiated Oppenheimer Outperform $14
Jan-12-15Reiterated Maxim Group Buy $10 → $11
Jan-09-15Reiterated MLV & Co Buy $6 → $9
Jan-09-15Reiterated Maxim Group Buy $10 → $11
Dec-19-14Reiterated Maxim Group Buy $8 → $10
May-08-14Reiterated Maxim Group Buy $17 → $11
Mar-14-14Reiterated MLV & Co Buy $9 → $11
Oct-08-13Reiterated Maxim Group Buy $19
Jan-05-12Initiated William Blair Outperform
Dec-01-11Initiated Global Hunter Securities Buy $6
Jan-17-20 05:12AM  Did You Manage To Avoid Agenus's (NASDAQ:AGEN) 22% Share Price Drop? Simply Wall St.
Jan-09-20 10:59AM  Agenus Announces the Appointment of Dr. Jennifer Buell to the position of President and COO PR Newswire
09:48AM  Agenus Initiates Phase I Study on Oncology Candidate AGEN1223 Zacks
Jan-08-20 10:04AM  Amicus (FOLD) Provides Updates on AT-GAA for Pompe Disease Zacks
08:30AM  Agenus Commences Phase 1 trial with AGEN1223 PR Newswire
Jan-03-20 10:54AM  Innate Pharma's Filing for Leukemia Drug Accepted in Europe Zacks
09:55AM  Pulmatrix Surges on License Agreement With Johnson & Johnson Zacks
09:41AM  Amicus Progresses on Pipeline Development Amid Competition Zacks
09:01AM  Arena (ARNA) Expands Strategic Deal With Beacon Discovery Zacks
Dec-19-19 10:37PM  Here is What Hedge Funds Think About Agenus Inc (AGEN) Insider Monkey
07:30AM  Agenus Commences Combination Trial of its Next-Gen CTLA-4 with its PD-1 Antibody PR Newswire
Dec-16-19 12:00PM  All You Need to Know About Agenus (AGEN) Rating Upgrade to Buy Zacks
Dec-05-19 09:42PM  Edited Transcript of AGEN earnings conference call or presentation 4-Nov-19 1:30pm GMT Thomson Reuters StreetEvents
Dec-04-19 11:30AM  Agenus (AGEN) Up 24.5% Since Last Earnings Report: Can It Continue? Zacks
Nov-20-19 09:39AM  Is the Options Market Predicting a Spike in Agenus (AGEN) Stock? Zacks
Nov-18-19 09:50AM  Moving Average Crossover Alert: Agenus Zacks +18.28%
Nov-13-19 09:05AM  Catalyst's (CPRX) Q3 Earnings Beat Estimates, Sales Miss Zacks
Nov-12-19 12:48PM  Agenus to Host R&D Day November 15, 2019 PR Newswire
09:52AM  Amicus' (FOLD) Shares Rise on Q3 Earnings & Revenue Beat Zacks
07:20AM  The Daily Biotech Pulse: Reata, Kadmon Clinical Readouts, Apyx Medical's Earnings Beat Benzinga
Nov-11-19 08:00AM  Agenus receives $10M from UroGen Pharma for rights to Zalifrelimab (CTLA-4) for intravesical treatment of urinary tract cancers PR Newswire +9.24%
07:10AM  Will Agenus Continue to Surge Higher? Zacks
Nov-08-19 08:14AM  The Daily Biotech Pulse: Therapix Calls Off Merger, Alimera's Reverse Split, 2 Biotechs To Debut Benzinga
Nov-07-19 10:00AM  Are You Looking for a Top Momentum Pick? Why Agenus (AGEN) is a Great Choice Zacks
09:00AM  Agenus (AGEN) Upgraded to Buy: What Does It Mean for the Stock? Zacks
Nov-06-19 01:53PM  Hedge Funds Have Never Been Less Bullish On Agenus Inc (AGEN) Insider Monkey +13.31%
Nov-05-19 11:09AM  Agenus (AGEN) Q3 Earnings Beat Estimates, Revenues Up Y/Y Zacks +5.21%
Nov-04-19 08:25AM  Agenus (AGEN) Reports Q3 Loss, Tops Revenue Estimates Zacks +7.72%
07:00AM  Agenus Provides Corporate Update with Third Quarter 2019 Financial Results PR Newswire
Oct-31-19 12:04PM  Agenus to Report Third Quarter 2019 Financial Results on November 4, 2019 and Host Conference Call and Webcast PR Newswire +5.28%
Oct-29-19 10:32AM  Analysts Estimate Agenus (AGEN) to Report a Decline in Earnings: What to Look Out for Zacks
Oct-19-19 08:26AM  Does Agenus Inc.'s (NASDAQ:AGEN) CEO Pay Matter? Simply Wall St.
Sep-30-19 04:34PM  Agenus to Present at the 2019 Cantor Global Healthcare Conference on October 4, 2019 PR Newswire
Sep-07-19 09:30AM  Why Is Agenus (AGEN) Up 19.2% Since Last Earnings Report? Zacks
Sep-04-19 11:52AM  Before You Buy Agenus Inc. (NASDAQ:AGEN), Consider Its Volatility Simply Wall St.
Aug-15-19 06:51PM  Edited Transcript of AGEN earnings conference call or presentation 8-Aug-19 12:30pm GMT Thomson Reuters StreetEvents
Aug-10-19 01:43AM  Agenus Inc (AGEN) Q2 2019 Earnings Call Transcript Motley Fool
Aug-09-19 11:09AM  Agenus (AGEN) Q2 Earnings Miss Estimates, Revenues Beat Zacks
Aug-08-19 09:35AM  Agenus (AGEN) Reports Q2 Loss, Tops Revenue Estimates Zacks +18.72%
07:30AM  Agenus Reports Second Quarter 2019 Financial Results and Provides Corporate Update PR Newswire
07:30AM  Agenus Milestone Triggers $7.5M Payment PR Newswire
Aug-06-19 10:56AM  Agenus to Report Second Quarter 2019 Financial Results on August 8, 2019 and Host Conference Call and Webcast PR Newswire +7.83%
Jul-26-19 11:04AM  Is Agenus (NASDAQ:AGEN) Using Too Much Debt? Simply Wall St.
Jul-18-19 02:00PM  Agenus Appoints Don Vidic as Vice President and Head of Commercial PR Newswire
Jul-08-19 09:00AM  Agenus (AGEN) Upgraded to Buy: What Does It Mean for the Stock? Zacks
Jun-26-19 06:24AM  Gilead Inks Deal With Carna Biosciences for Immuno-Oncology Zacks
Jun-20-19 09:36AM  How Many Agenus Inc. (NASDAQ:AGEN) Shares Do Institutions Own? Simply Wall St.
06:33AM  Gilead (GILD) Teams Up With Nurix for Cancer and Other Drugs Zacks
Jun-13-19 03:48PM  Agenus to Host Annual Meeting of Stockholders PR Newswire
Jun-11-19 03:44PM  Edited Transcript of AGEN earnings conference call or presentation 9-May-19 12:30pm GMT Thomson Reuters StreetEvents
Jun-08-19 09:31AM  Why Is Agenus (AGEN) Down 6.3% Since Last Earnings Report? Zacks
May-30-19 08:00AM  MiMedx Announces Comprehensive Board Refreshment Plan in Cooperation with Prescience Point PR Newswire -5.40%
May-24-19 10:53AM  Agenus' (AGEN) Pipeline Progression on Track Amid Competition Zacks
May-10-19 02:54PM  Agenus (AGEN) Q1 Earnings Beat Estimates, Revenues Miss Zacks
07:24AM  Agenus Inc (AGEN) Q1 2019 Earnings Call Transcript Motley Fool
May-09-19 09:05AM  Agenus (AGEN) Surpasses Q1 Earnings Estimates Zacks +8.27%
07:57AM  Agenus: 1Q Earnings Snapshot Associated Press
07:30AM  Agenus Reports First Quarter 2019 Financial Results and Provides Corporate Update PR Newswire
06:30AM  Agenus, Inc. to Host Earnings Call ACCESSWIRE
May-03-19 01:38PM  Agenus to Report First Quarter 2019 Financial Results on May 9, 2019 and Host Conference Call and Webcast PR Newswire
Apr-23-19 07:41AM  Imagine Owning Agenus (NASDAQ:AGEN) And Wondering If The 41% Share Price Slide Is Justified Simply Wall St.
Apr-13-19 09:30AM  Why Is Agenus (AGEN) Down 13% Since Last Earnings Report? Zacks
Apr-08-19 05:25PM  Gilead Files sNDA for Label Expansion of HIV Therapy Descovy Zacks
Apr-02-19 08:30AM  Agenus Begins Dosing with Next-Gen Anti-CTLA-4 Antibody PR Newswire
Mar-21-19 09:00AM  Agenus Announces Clinical Appointments PR Newswire
Mar-20-19 09:15AM  3 Top Growth Stocks to Buy Right Now Motley Fool
Mar-18-19 04:07PM  Edited Transcript of AGEN earnings conference call or presentation 14-Mar-19 12:30pm GMT Thomson Reuters StreetEvents
Mar-14-19 11:13AM  Agenus Wins $7.5M Milestone Payment From Gilead, Stock Up Zacks
10:55AM  Agenus Inc (AGEN) Q4 2018 Earnings Conference Call Transcript Motley Fool
09:30AM  Agenus (AGEN) Reports Q4 Loss, Lags Revenue Estimates Zacks
08:35AM  Agenus: 4Q Earnings Snapshot Associated Press
08:00AM  Agenus Reports Fourth Quarter and Full Year 2018 Financial Results and Provides Corporate Update PR Newswire
Mar-13-19 08:30AM  Agenus Milestone Triggers $7.5M Payment from Gilead PR Newswire
Mar-08-19 03:46PM  Gilead Reports Positive Data on HIV Drugs Biktarvy & Descovy Zacks -5.65%
Mar-07-19 01:50PM  Gilead Reports Positive Data on HIV Drugs Biktarvy & Descovy Zacks +6.79%
Mar-03-19 07:09PM  The 3 Oldest Members of Biotech's Billion-Burned Club Motley Fool
Feb-20-19 08:30AM  Analysis: Positioning to Benefit within Micron Technology, Caterpillar, Agenus, Fossil Group, Marathon Petroleum, and Geo Group Research Highlights Growth, Revenue, and Consolidated Results GlobeNewswire -5.68%
Feb-19-19 08:30AM  Agenus Launches First Asset-Backed Digital-Security Offering in Healthcare PR Newswire -12.19%
Feb-15-19 11:41AM  Agenus to Host Call to Launch First Asset-Backed Digital-Security Offering in Healthcare on February 19, 2019 PR Newswire
Feb-08-19 10:25AM  Why Agenus Inc. Stock Took Flight in January Motley Fool
Feb-05-19 08:43AM  Gilead (GILD) Q4 Earnings Miss Estimates, Revenues Beat Zacks
Jan-31-19 07:18PM  Will Gilead (GILD) Q4 Earnings Disappoint on Weak HCV Sales? Zacks
Jan-29-19 08:00AM  Atomic Capital Kicks off Investor Forum Announcing Digital Offering for NASDAQ-Traded Biotech Group, Agenus Inc. PR Newswire
08:00AM  Agenus to Launch the First Asset-Backed Digital Security Offering in Healthcare PR Newswire
Jan-24-19 08:30AM  Agenus Closes $150 Million Immuno-Oncology Transaction with Gilead PR Newswire
Jan-09-19 07:30AM  Research Report Identifies Conagra Brands, W.R. Grace, International Flavors & Fragrances, Spirit Airlines, Sunstone Hotel Investors, and Agenus with Renewed Outlook Fundamental Analysis, Calculating Forward Movement GlobeNewswire
Jan-08-19 08:38AM  Agenus (AGEN) Surges: Stock Moves 9.4% Higher Zacks
Jan-07-19 12:17PM  Why Agenus Stock Is Spiking Today Motley Fool +9.43%
Jan-06-19 10:00AM  All the Pre-JPM News Healthcare Investors Need to Know Motley Fool
Jan-04-19 08:31AM  Are Options Traders Betting on a Big Move in Agenus (AGEN) Stock? Zacks +6.07%
Jan-03-19 04:31PM  Why Celgene, Agenus, and Incyte Jumped Today Motley Fool +11.55%
04:22PM  Here's Why Agenus Shares Rose as Much as 13.5% Today Motley Fool
11:30AM  Agenus Awarded Grant to Enable QS-21 Innovations PR Newswire
Dec-26-18 10:32AM  3 Biotech Stocks That Are Too Cheap to Ignore Motley Fool +12.61%
09:34AM  Biotech Stock Roundup: ALXN, ACOR Drugs' Get FDA Nod, AGEN up on GILD Deal Zacks
Dec-23-18 09:03AM  2 Beaten-Down Biotech Stocks That Look Like Bargains Now Motley Fool
Dec-21-18 09:19AM  Agenus' Stock Up 23% on Immuno-Oncology Deal With Gilead Zacks -8.87%
08:00AM  Major Biotech Deals Making Sector Red Hot ACCESSWIRE
Dec-20-18 12:48PM  Why Agenus Stock Is Soaring Today Motley Fool +23.38%
09:30AM  4 Biotech Stocks Making Moves on Thursday December 20, 2018 ACCESSWIRE
Agenus Inc., a clinical-stage immuno-oncology company, focuses on the discovery and development of therapies that engage the body's immune system to fight cancer. The company offers Retrocyte Display, an antibody discovery platform for the identification of fully-human and humanized monoclonal antibodies; SECANT yeast display, an antibody discovery platform used for the generation of novel monoclonal antibodies; and phage display technologies. It is also developing checkpoint modulating antibody candidates targeting GITR, OX40, TIM-3, LAG-3, and others. In addition, the company develops vaccine programs, including Prophage vaccine candidate; AutoSynVax, a synthetic neoantigen; and PhosPhoSynVax, a vaccine candidate designed to induce immunity against a class of tumor specific neoepitopes. Further, it develops QS-21 Stimulon adjuvant, a saponin-based vaccine adjuvant. Additionally, the company engages in the development of CTLA-4 and PD-1 antagonists; and anti-CTLA-4, CD137, and TIGIT antibodies, as well as various multi-specific antibodies that are under various stages of development. Agenus Inc. has collaboration agreements with Incyte Corporation, Merck Sharpe & Dohme, and Recepta Biopharma SA.; and collaboration with Gilead Sciences, Inc. to develop immuno-oncology therapies. The company was formerly known as Antigenics Inc. and changed its name to Agenus Inc. in January 2011. Agenus Inc. was founded in 1994 and is headquartered in Lexington, Massachusetts.